subject: UMLS:C0376659

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Advanced Adenocarcinoma

tested_intervention: unsure


subject: UNII:DPT0O3T46P

object_name: Recurrent Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Adenocarcinoma, metastatic


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22

object_name: Recurrent Malignant Solid Neoplasm


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C5190278

subject_name: SMOF lipid

object_name: leukemia

tested_intervention: yes


subject: UMLS:C5190278

object_name: childhood leukemia


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:4EQZ6YO2HI

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: CHEBI:37924

subject_name: Atazanavir

object_name: coronary microvascular disorder


subject: CHEBI:31781

subject_name: Lopinavir


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: type 1 diabetes mellitus 1


subject: CHEBI:28240

subject_name: dichloroacetate

object_name: lactic acidosis


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline

object_name: familial spontaneous pneumothorax


subject: UNII:5TAA004E22

object_name: periodontitis


subject: PR:000005931


subject: CHEBI:36704

subject_name: Imiquimod

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: ACUTE ALCOHOL WITHDRAWAL


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:2914

subject_name: Atracurium

object_name: obesity


subject: CHEBI:9123

subject_name: Sertraline

object_name: fragile X syndrome


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Recurrent disease


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: squamous cell carcinoma


subject: CHEBI:46058

object_name: Neck Carcinoma


subject: CHEBI:46058

object_name: head and neck neoplasm


subject: CHEBI:46058

object_name: head and neck cancer


subject: CHEBI:46058


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:16991

subject_name: DNA

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: KEGG.COMPOUND:C00046

subject_name: RNA


subject: PR:000023786

subject_name: ribonuclease I


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: lymphedema


subject: CHEBI:71196

object_name: Lymphedema, CTCAE


subject: UMLS:C0308803

subject_name: dexamethasone injection

object_name: Postoperative Complications


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:71272


subject: CHEBI:71272

object_name: Obesity, CTCAE


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: low grade glioma


subject: CHEBI:75045

object_name: BRAF V600 Protein Variation


subject: CHEBI:75045

object_name: Low grade glioma of brain


subject: CHEBI:75045

object_name: Recurrent Low Grade Glioma


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: UMLS:C0453273

subject_name: cranberry preparation

object_name: arteriosclerosis disorder


subject: UMLS:C0453273

object_name: atherosclerosis


subject: UMLS:C2723348

subject_name: ANNONA MURICATA

object_name: hypertension


subject: UMLS:C2723348

object_name: Hypertension, CTCAE


subject: CHEBI:47612

subject_name: Bezafibrate

object_name: acute myocardial infarction


subject: CHEBI:47612

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:16302

object_name: preeclampsia


subject: CHEBI:16302

object_name: Decreased circulating vitamin E concentration


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C1676059

subject_name: TMC 278

object_name: Hepatic impairment


subject: UMLS:C1676059

object_name: AIDS


subject: CHEBI:68606

subject_name: Rilpivirine


subject: CHEBI:68606


subject: UMLS:C3666839

subject_name: Rixubis

object_name: hemophilia B


subject: UMLS:C3666839

object_name: hemophilia B leyden


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: leiomyoma


subject: UMLS:C1518041

object_name: uterine fibroid


subject: CHEBI:5523

subject_name: Goserelin


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: metabolic disease


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: cystic fibrosis


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: gallbladder cancer


subject: UMLS:C3641122


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: type C thymoma


subject: CHEBI:15367

subject_name: Tretinoin

object_name: non-small cell lung carcinoma


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: influenza


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324

object_name: respiratory tract infectious disorder


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: inherited torticollis


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: rheumatoid arthritis


subject: CHEBI:50275

object_name: osteoarthritis


subject: CHEBI:50275

object_name: Low back pain


subject: CHEBI:77260

subject_name: Omeprazole

object_name: duodenal ulcer


subject: CHEBI:77260

object_name: Duodenal Ulcer, CTCAE


subject: CHEBI:77260

object_name: Gastric Ulcer, CTCAE


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:45716

subject_name: Vorinostat

object_name: bladder tumor


subject: CHEBI:27732

subject_name: Caffeine

object_name: AOD effects and consequences


subject: CHEBI:27999

subject_name: Tolbutamide


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: stroke disorder


subject: CHEBI:6503

object_name: cerebrovascular disorder


subject: CHEBI:6503

object_name: Stroke (heart beat)


subject: CHEBI:6503

object_name: Stroke, CTCAE


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:43755


subject: CHEBI:43755


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Childhood Breast Carcinoma


subject: UMLS:C0013227

object_name: breast carcinoma


subject: UMLS:C0013227

object_name: breast cancer


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:94531

subject_name: belinostat

object_name: adult hepatocellular carcinoma


subject: CHEBI:94531

object_name: liver carcinoma


subject: CHEBI:94531

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:94531

object_name: advanced adult primary liver cancer


subject: CHEBI:94531

object_name: Recurrent Adult Liver Carcinoma


subject: UMLS:C4732971

subject_name: SP 02L

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C4732971

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C3859612

subject_name: Hyqvia

object_name: inborn error of immunity


subject: UMLS:C3859612

object_name: secondary immune deficiency


subject: PUBCHEM.COMPOUND:13444038

subject_name: Sugemalimab

object_name: non-small cell lung carcinoma


subject: GTOPDB:12342

subject_name: sugemalimab


subject: CHEMBL.COMPOUND:CHEMBL4594535

subject_name: SUGEMALIMAB


subject: UMLS:C4733610


subject: CHEBI:86465

subject_name: Kalinite

object_name: Alzheimer disease


subject: UNII:I7T908772F

subject_name: alum


subject: CHEBI:86463

subject_name: Potassium alum


subject: UMLS:C4305639


subject: MESH:C089950

subject_name: MF59 oil emulsion


subject: MESH:C000722724


subject: CHEBI:34967

subject_name: Rimonabant

object_name: Prediabetes


subject: UNII:16F6055SMG

subject_name: VEBICORVIR

object_name: chronic hepatitis B virus infection


subject: UNII:16F6055SMG

object_name: hepatitis B


subject: DRUGBANK:DB18784

subject_name: Vebicorvir


subject: DRUGBANK:DB18784


subject: CHEBI:16302

object_name: relapsing-remitting multiple sclerosis


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:2948

subject_name: Azathioprine

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:2948

object_name: vitiligo


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:71200


subject: UMLS:C1541394

subject_name: TRAIL-R1 mAb


subject: CHEBI:27732

subject_name: Caffeine

object_name: rheumatoid arthritis


subject: CHEBI:7772

subject_name: omeprazole


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:18067

subject_name: Phylloquinone


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C5417821

object_name: plasma cell myeloma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: carcinoid tumor


subject: CHEBI:231679

object_name: digestive system neuroendocrine neoplasm


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: failure; transplant, kidney


subject: CHEBI:72296

subject_name: Apixaban

object_name: sickle cell disease


subject: CHEBI:72296

object_name: Vaso-Occlusive Crisis


subject: CHEBI:64816

object_name: metastatic colorectal cancer


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: UMLS:C4764272

subject_name: Botensilimab


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB


subject: UMLS:C4526708


subject: UMLS:C5238912

subject_name: Anti-CD137 Agonistic Monoclonal Antibody AGEN2373


subject: CHEBI:17026

subject_name: Progesterone

object_name: pregnancy; twin, affecting fetus or newborn


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: xerophthalmia


subject: CHEBI:150712

object_name: Dry Eye Syndrome, CTCAE


subject: GTOPDB:13805

subject_name: batoclimab

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: GTOPDB:13805

object_name: Guillain-Barre syndrome, familial


subject: UNII:C98V9UMX3D

subject_name: BATOCLIMAB


subject: UNII:C98V9UMX3D


subject: UMLS:C5419322

subject_name: Batoclimab


subject: UMLS:C5419322


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: nasal cavity and paranasal sinus carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:4672

subject_name: Docetaxel


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:70707

subject_name: Vilazodone

object_name: anxiety


subject: CHEBI:70707

object_name: anxiety disorder


subject: CHEBI:70707

object_name: Anxiety symptoms


subject: CHEBI:70707

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:70707

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:70707

object_name: Comorbidity


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Heartburn


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Left ventricular hypertrophy


subject: UNII:1C6V77QF41

object_name: Left Ventricular Hypertrophy by ECG Finding


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: sickle cell disease


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:89324

object_name: Intestinal Failure


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842


subject: CHEBI:27300


subject: UMLS:C3537249


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Hypoplastic anemia


subject: CHEBI:4445

subject_name: Desflurane

object_name: coronary artery disorder


subject: CHEBI:4445

object_name: coronary atherosclerosis


subject: CHEBI:61057

object_name: lymphedema


subject: CHEBI:61057

object_name: Lymphedema, CTCAE


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:20993

subject_name: GLUCOSAMINE

object_name: Overweight


subject: CHEBI:28393

subject_name: D-glucosamine


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Iron absorption level


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: Prediabetes


subject: CHEBI:32020

subject_name: Pitavastatin


subject: UMLS:C0751598

subject_name: Alferon

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C0751598

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: UMLS:C0304604

subject_name: Topical form corticosteroids

object_name: corneal ulcer


subject: UMLS:C0304604

object_name: Corneal Ulcer, CTCAE


subject: UMLS:C0304604

object_name: Eye Infections, Bacterial


subject: PUBCHEM.COMPOUND:9941750

object_name: Helicobacter pylori infection


subject: CHEBI:176381

subject_name: Diosmin


subject: UMLS:C0215217

subject_name: Daflon


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: adrenogenital syndrome


subject: CHEBI:41879

object_name: congenital adrenal hyperplasia


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: pseudoxanthoma elasticum (inherited or acquired)


subject: UNII:15C2VL427D

object_name: elastoma


subject: UNII:15C2VL427D

object_name: autosomal recessive inherited pseudoxanthoma elasticum


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:89324

object_name: arteriosclerosis disorder


subject: CHEBI:89324

object_name: atherosclerosis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UNII:1C6V77QF41


subject: UMLS:C1527264

object_name: aspergillosis


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: Complex congenital heart disease


subject: CHEBI:176381

object_name: venous insufficiency


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: Light chain (AL) amyloidosis


subject: UMLS:C2917392

subject_name: Typical Antipsychotic

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:77335690

object_name: Recurrent tumor


subject: PUBCHEM.COMPOUND:77335690

object_name: Complications of treatment


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:85083


subject: CHEBI:176724

subject_name: Etiracetam

object_name: tardive dyskinesia


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:80961

object_name: rectum adenocarcinoma


subject: PUBCHEM.COMPOUND:146430058

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:146430058

object_name: acute lymphoblastic leukemia


subject: UNII:VW83Y2JLZ5

subject_name: ENZOMENIB


subject: UNII:VW83Y2JLZ5


subject: CHEBI:145372

subject_name: Gilteritinib


subject: CHEBI:68452

subject_name: azole


subject: CHEBI:68452


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: stage IB pancreatic cancer


subject: MESH:C520255

object_name: stage IIA pancreatic cancer


subject: MESH:C520255

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: MESH:C520255

object_name: stage IIB pancreatic cancer


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: GTOPDB:12990

subject_name: sintilimab


subject: GTOPDB:12990


subject: GTOPDB:12990


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: CHEBI:50859

subject_name: Bexarotene

object_name: Kaposi Sarcoma


subject: CHEBI:50859

object_name: HIV infection


subject: CHEBI:29708

subject_name: Zinc gluconate

object_name: type 2 diabetes mellitus


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: UMLS:C5222462

subject_name: Liraglutide Injection


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Childhood Acute Myeloid Leukemia with Minimal Differentiation


subject: UMLS:C0003442

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C0003442

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: UMLS:C0003442

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UMLS:C0003442

object_name: T-cell childhood acute lymphocytic leukemia


subject: UMLS:C0003442

object_name: childhood acute monocytic leukemia


subject: UMLS:C0003442

object_name: Childhood Acute Monoblastic Leukemia


subject: UMLS:C0003442

object_name: childhood acute megakaryoblastic leukemia


subject: UMLS:C0003442

object_name: Chronic lymphocytic leukaemia stage 2


subject: UMLS:C0003442

object_name: B-cell adult acute lymphocytic leukemia


subject: UMLS:C0003442

object_name: T-cell adult acute lymphocytic leukemia


subject: UMLS:C0003442

object_name: Chronic lymphocytic leukaemia stage 3


subject: UMLS:C0003442

object_name: adult acute monocytic leukemia


subject: UMLS:C0003442

object_name: acute megakaryoblastic leukemia in adult


subject: UMLS:C0003442

object_name: primary cutaneous B-cell lymphoma


subject: UMLS:C0003442

object_name: Adult Acute Monoblastic Leukemia


subject: UMLS:C0003442

object_name: Childhood Acute Erythroid Leukemia


subject: UMLS:C0003442

object_name: Chronic lymphocytic leukaemia stage 4


subject: UMLS:C0003442

object_name: Chronic lymphocytic leukaemia stage 1


subject: UMLS:C0003442

object_name: Adult Pure Erythroid Leukemia


subject: UMLS:C0003442

object_name: prolymphocytic leukemia


subject: UMLS:C0003442

object_name: Adult Erythroleukemia


subject: UMLS:C0003442

object_name: Myelofibrosis due to another disorder


subject: UMLS:C0003442

object_name: Burkitt lymphoma


subject: UMLS:C0003442

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C0003442

object_name: Adult Burkitt Lymphoma


subject: CHEBI:174615

object_name: Childhood Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:174615

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:174615

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:174615

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:174615

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:174615

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:174615

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:174615

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:174615

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:174615

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:174615

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:174615

object_name: prolymphocytic leukemia


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:6888

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:6888

object_name: Blast Phase


subject: CHEBI:6888


subject: CHEBI:6888

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:6888

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:6888

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:6888

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:6888


subject: CHEBI:6888

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:6888

object_name: chronic myelomonocytic leukemia


subject: CHEBI:6888

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:6888


subject: CHEBI:6888

object_name: Myelofibrosis due to another disorder


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Childhood Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:168396

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:168396

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:168396

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:168396

object_name: childhood acute monocytic leukemia


subject: CHEBI:168396

object_name: Childhood Acute Monoblastic Leukemia


subject: CHEBI:168396

object_name: childhood acute megakaryoblastic leukemia


subject: CHEBI:168396

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:168396

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:168396

object_name: adult acute monocytic leukemia


subject: CHEBI:168396

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:168396

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:168396

object_name: Childhood Acute Erythroid Leukemia


subject: CHEBI:168396

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:168396

object_name: Adult Erythroleukemia


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: MESH:C487773

subject_name: trans-sodium crocetinate

object_name: interstitial lung disease


subject: PUBCHEM.COMPOUND:90488848

object_name: scleritis


subject: GTOPDB:1331

subject_name: ACTH


subject: UMLS:C3539087

subject_name: ACTH and synthetic analog preparations


subject: CHEBI:3892

subject_name: Corticotropin


subject: UMLS:C0718234

subject_name: Acthar


subject: UMLS:C2825093

subject_name: Adrenocorticotropic Hormone [EPC]


subject: UMLS:C0972569

subject_name: Electrophoresis Gel


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: acquired polycythemia vera


subject: CHEBI:15940

subject_name: Niacin

object_name: Skin Manifestations


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: inhalational anthrax


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage IV Uveal Melanoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Uveal Melanoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIC Uveal Melanoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Uveal Melanoma AJCC v7


subject: UMLS:C3851370

subject_name: tannate gelatin

object_name: diarrhea


subject: UMLS:C3851370

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C3851370

object_name: Diarrhea, CTCAE


subject: CHEBI:73896

subject_name: Gly-D-Thr


subject: CHEBI:73896


subject: CHEBI:73896


subject: CHEBI:73920

subject_name: Gly-Thr


subject: CHEBI:73920


subject: CHEBI:73920


subject: UMLS:C3813201

subject_name: Oral Rehydration Solution OS-1


subject: UMLS:C3813201


subject: UMLS:C3813201


subject: UMLS:C0078516

subject_name: World Health Organization oral rehydration solution


subject: UMLS:C0078516


subject: UMLS:C0078516


subject: UMLS:C1443923

subject_name: Oral rehydration solution


subject: UMLS:C1443923


subject: UMLS:C1443923


subject: MESH:C034130

subject_name: ORALIT


subject: MESH:C034130


subject: MESH:C034130


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Pure Erythroid Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Acute Monoblastic Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: adult acute monocytic leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:3368

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:95067

subject_name: Iniparib

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL4297803

subject_name: PEGZILARGINASE

object_name: Argininemia


subject: CHEMBL.COMPOUND:CHEMBL4297803

object_name: Hyperargininemia


subject: UMLS:C4086734


subject: UMLS:C4086734


subject: UNII:DSS3BE2ZXN

subject_name: tusamitamab ravtansine

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:DSS3BE2ZXN

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C3896771


subject: UMLS:C3896771


subject: UNII:HOY74VZE0M

subject_name: gadoxetate

object_name: Liver Abscess


subject: UNII:HOY74VZE0M

object_name: liver neoplasm


subject: UNII:HOY74VZE0M

object_name: carcinoma


subject: UNII:HOY74VZE0M

object_name: adenoma


subject: UMLS:C0675788

subject_name: Eovist


subject: UMLS:C0675788


subject: UMLS:C0675788


subject: UMLS:C0675788


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: autism


subject: UMLS:C2981806

object_name: Liquid Tumor


subject: UMLS:C2981806

object_name: leukemia


subject: UMLS:C2981806

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: medullary thyroid gland carcinoma


subject: UNII:Y68179SY2L


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: thrombocytopenia


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Mountain Sickness


subject: CHEBI:38290

object_name: acute mountain sickness


subject: CHEBI:38290

object_name: altitude sickness


subject: CHEBI:38290

object_name: chronic graft versus host disease


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:8494

subject_name: Propiverine hydrochloride

object_name: interstitial cystitis


subject: CHEBI:8493

subject_name: Propiverine


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: primary dysautonomia


subject: UMLS:C4086546

object_name: dysautonomia


subject: UMLS:C4086546

object_name: autonomic nervous system disorder


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Metastatic Biliary Tract Carcinoma


subject: CHEBI:68646

object_name: Metastatic Bile Duct Carcinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: UNII:YK5DTP8NHU

object_name: castration-resistant prostate carcinoma


subject: UNII:YK5DTP8NHU

object_name: metastatic prostate carcinoma


subject: UNII:YK5DTP8NHU

object_name: Castration Levels of Testosterone


subject: UNII:YK5DTP8NHU

object_name: Adenocarcinoma of the prostate stage IV


subject: UNII:YK5DTP8NHU

object_name: PSA Progression


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor

object_name: cardiotoxicity


subject: UMLS:C0003015


subject: GTOPDB:7684

subject_name: lebrikizumab

object_name: chronic obstructive pulmonary disease


subject: CHEMBL.COMPOUND:CHEMBL1743035

subject_name: LEBRIKIZUMAB


subject: UMLS:C1881890


subject: CHEBI:92607

subject_name: Methylergometrine

object_name: postpartum hemorrhage


subject: CHEBI:92607

object_name: Post-partum hemorrhage


subject: CHEBI:92607

object_name: Uterine Inertia


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: cocaine dependence


subject: CHEBI:6539

subject_name: Lorazepam


subject: UMLS:C5554971

subject_name: Anti-CD40 Agonist Antibody YH003

object_name: mucosal melanoma


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin


subject: CHEBI:71416

subject_name: phenazopyridine

object_name: Dysfunctional voiding


subject: CHEBI:71416

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:135580740

subject_name: Phenazo


subject: PUBCHEM.COMPOUND:135580740


subject: UNII:K2J09EMJ52

subject_name: Phenazopyridine


subject: UNII:K2J09EMJ52


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: ovarian cancer


subject: CHEBI:5801

object_name: ovarian neoplasm


subject: CHEBI:5801

object_name: ovarian carcinoma


subject: CHEBI:7496

subject_name: Nelfinavir


subject: CHEBI:7496


subject: CHEBI:7496


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Arterial Stiffness


subject: CHEBI:15407

subject_name: Ephedrine

object_name: supine hypotensive syndrome


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:18357

subject_name: Norepinephrine


subject: GTOPDB:8416

object_name: Chronic uremia


subject: GTOPDB:8416

object_name: chronic kidney disease


subject: UMLS:C5666941

subject_name: ER Alpha-targeting Chimeric Protein Degrader AC682

object_name: Childhood Breast Carcinoma


subject: UMLS:C5666941

object_name: breast carcinoma


subject: UMLS:C5666941

object_name: breast cancer


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Stomach cancer


subject: CHEBI:85994

object_name: gastric cancer


subject: CHEBI:16374

subject_name: Menatetrenone

object_name: Prediabetes


subject: CHEBI:16374

object_name: Diabetes


subject: CHEBI:16374

object_name: diabetes mellitus


subject: CHEBI:38940

subject_name: Sunitinib

object_name: skin melanoma


subject: CHEBI:17596

subject_name: Inosine

object_name: relapsing-remitting multiple sclerosis


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: euthyroid Graves orbitopathy


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C3896702

subject_name: Yttrium Y 90-DOTA-di-HSG Peptide IMP-288

object_name: metastatic colorectal cancer


subject: CHEBI:48131

subject_name: Azelaic acid


subject: CHEBI:48131


subject: CHEBI:48131


subject: UMLS:C0935915

object_name: macular degeneration


subject: UMLS:C0935915

object_name: age-related macular degeneration


subject: UMLS:C0935915

object_name: retinitis pigmentosa 30


subject: UNII:4WE915J1KX

subject_name: squalamine lactate


subject: UNII:4WE915J1KX


subject: UNII:4WE915J1KX


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: hiatus hernia


subject: UMLS:C4287724

object_name: wet macular degeneration


subject: UMLS:C5706452

subject_name: Anti-PVR Monoclonal Antibody NTX-1088

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C5706452

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706452

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5706452

object_name: Embolism, Tumor


subject: UMLS:C5706452

object_name: Neoplasm Metastasis


subject: UMLS:C5706452

object_name: Childhood Solid Neoplasm


subject: UMLS:C5706452

object_name: Adult Solid Neoplasm


subject: UMLS:C5706452

object_name: Solid Neoplasm


subject: UMLS:C5706452

object_name: cancer


subject: UMLS:C5706452

object_name: neoplasm


subject: DRUGBANK:DB17545

subject_name: Jaktinib

object_name: myeloproliferative neoplasm


subject: DRUGBANK:DB17545

object_name: Myelodysplasia


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: aortic stenosis


subject: CHEBI:26536

subject_name: retinoic acid

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: CHEBI:28870


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:6067

subject_name: Isotretinoin


subject: UMLS:C5854500

subject_name: Gemcitabine Liposome FF-10832

object_name: Advanced Urothelial Carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UMLS:C3852731

subject_name: Xamiol gel

object_name: psoriasis vulgaris


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: colorectal cancer


subject: UNII:15C2VL427D

object_name: colorectal carcinoma


subject: UNII:15C2VL427D

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: schizophrenia


subject: CHEBI:30314

object_name: Weight loss


subject: CHEBI:30314

object_name: Weight Loss, CTCAE


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:17026

subject_name: Progesterone

object_name: Twin pregnancy


subject: UMLS:C2757070

subject_name: Progesterone [EPC]

object_name: premature birth (history)


subject: UMLS:C2757070


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: pancreatic neoplasm


subject: UNII:5S371K6132

object_name: exocrine pancreatic carcinoma


subject: UNII:5S371K6132

object_name: malignant pancreatic neoplasm


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: acute lymphoblastic leukemia


subject: CHEBI:6887

object_name: brain neoplasm


subject: UMLS:C5201249

subject_name: CXCR4 INHIBITOR X4P-001

object_name: triple-negative breast carcinoma


subject: UMLS:C5201249

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:L4C1UY2NYH

subject_name: Inavolisib

object_name: Childhood Solid Neoplasm


subject: UNII:L4C1UY2NYH

object_name: Adult Solid Neoplasm


subject: UNII:L4C1UY2NYH

object_name: Solid Neoplasm


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:3387

subject_name: Carbamazepine


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: cancer


subject: UMLS:C5700219

object_name: neoplasm


subject: CHEBI:2955

subject_name: Azithromycin

object_name: pulmonary tuberculosis


subject: DRUGBANK:DB18505


subject: UMLS:C0338265

subject_name: Cisplatin/Gemcitabine

object_name: bladder tumor


subject: UMLS:C0338265

object_name: urinary bladder carcinoma


subject: UMLS:C0338265

object_name: urinary bladder cancer


subject: UMLS:C0338265

object_name: childhood bladder carcinoma


subject: MESH:D000084922

subject_name: Resistant Starch

object_name: chronic kidney disease


subject: CHEBI:231356

subject_name: Varlitinib

object_name: pancreatic neoplasm


subject: CHEBI:231356

object_name: exocrine pancreatic carcinoma


subject: CHEBI:231356

object_name: malignant pancreatic neoplasm


subject: UMLS:C4759996

subject_name: Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance)


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C1579410

subject_name: Nucleoside Analogs

object_name: Advanced cancer


subject: UMLS:C1579410


subject: UMLS:C1579410


subject: UMLS:C1579410


subject: CHEBI:60783

subject_name: nucleoside analogue


subject: CHEBI:60783


subject: CHEBI:60783


subject: CHEBI:60783


subject: UMLS:C3537141

subject_name: Nucleoside Analog [EPC]


subject: UMLS:C3537141


subject: UMLS:C3537141


subject: UMLS:C3537141


subject: CHEBI:31355

subject_name: Carboplatin

object_name: large cell medulloblastoma


subject: CHEBI:31355

object_name: Anaplastic Medulloblastoma


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: adult medulloblastoma


subject: CHEBI:6067


subject: CHEBI:6067


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:147912

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:147912

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:71464

subject_name: Palmidrol

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:71464


subject: CHEBI:71464


subject: CHEBI:71464

object_name: Malignant Solid Neoplasm


subject: UMLS:C5391556

object_name: neuroendocrine neoplasm


subject: CHEBI:74947

subject_name: Thalidomide

object_name: chronic prostatitis


subject: CHEBI:74947

object_name: pelvic pain on the left


subject: CHEBI:74947

object_name: pelvic pain occurs with urination


subject: CHEBI:74947

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:74947

object_name: pelvic pain decreasing in severity


subject: CHEBI:74947

object_name: Pelvic pain female


subject: CHEBI:74947

object_name: pelvic pain increasing in severity


subject: CHEBI:74947

object_name: male pelvic pain


subject: CHEBI:74947

object_name: pelvic pain to the rear


subject: CHEBI:74947

object_name: pelvic pain on the right


subject: CHEBI:74947

object_name: pelvic pain decreasing in frequency


subject: CHEBI:74947

object_name: Pelvic pain


subject: CHEBI:74947

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:74947

object_name: pelvic pain causes awakening at night


subject: CHEBI:74947

object_name: pelvic pain increasing in frequency


subject: CHEBI:74947

object_name: pelvic pain occurs with intercourse


subject: CHEBI:74947

object_name: pelvic pain in front


subject: UMLS:C1186762

subject_name: Dakins Solution

object_name: Childhood Breast Carcinoma


subject: UMLS:C1186762

object_name: breast carcinoma


subject: UMLS:C1186762

object_name: breast cancer


subject: UMLS:C1186762

object_name: Skin Reaction Secondary to Radiation Therapy


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: BCLC Stage B Hepatocellular Carcinoma


subject: UNII:5S371K6132

object_name: BCLC Stage C Hepatocellular Carcinoma


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: UMLS:C4547969


subject: CHEBI:67271


subject: CHEBI:67271

object_name: diffuse gastric adenocarcinoma


subject: CHEBI:67271

object_name: recurrent gastric cancer


subject: CHEBI:67271

object_name: Gastric Mixed Adenocarcinoma


subject: CHEBI:67271

object_name: gastric intestinal type adenocarcinoma


subject: UNII:660M185X4D

object_name: type 1 diabetes mellitus


subject: CHEBI:36796

subject_name: duloxetine

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:36796

object_name: Back pain


subject: CHEBI:36796

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:36796

object_name: age


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection

object_name: cancer


subject: UMLS:C2729286

subject_name: Injection, docetaxel, 1 mg administered


subject: UMLS:C5203163

subject_name: Docetaxel Liquid Injection


subject: UMLS:C3896866

subject_name: FGF/FGFR Pathway Inhibitor E7090

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: hemolytic-uremic syndrome


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UMLS:C5783515

subject_name: KRAS G12C Inhibitor HBI-2438

object_name: Childhood Solid Neoplasm


subject: UMLS:C5783515

object_name: Adult Solid Neoplasm


subject: UMLS:C5783515

object_name: Solid Neoplasm


subject: UMLS:C5783515

object_name: non-small cell lung carcinoma


subject: UMLS:C5783515

object_name: pancreatic neoplasm


subject: UMLS:C5783515

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5783515

object_name: malignant pancreatic neoplasm


subject: UMLS:C5783515

object_name: colorectal cancer


subject: UMLS:C5783515

object_name: colorectal carcinoma


subject: UMLS:C5783515

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5783515

object_name: colon carcinoma


subject: UMLS:C5783515

object_name: colon cancer


subject: UMLS:C5783515

object_name: lung cancer


subject: UMLS:C5783515

object_name: lung neoplasm


subject: UMLS:C5783515

object_name: lung carcinoma


subject: UMLS:C5783515

object_name: cancer


subject: UMLS:C5783515

object_name: neoplasm


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Intraoperative Hemorrhage


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:8428

subject_name: Procainamide

object_name: atrial fibrillation


subject: CHEBI:8428

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:8428

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Locally Recurrent Malignant Neoplasm


subject: CHEBI:2704

object_name: hormone receptor-positive breast cancer


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:230905

subject_name: Ribociclib


subject: UMLS:C2830141

object_name: pancreatic neoplasm


subject: UNII:XSZ53G39H5

subject_name: Brolucizumab

object_name: diabetic macular edema


subject: PUBCHEM.COMPOUND:444033

subject_name: Ciclesonide

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C0051764

subject_name: Ampligen

object_name: HIV infection


subject: UNII:82MI0GT75Z

object_name: multiple sclerosis


subject: UNII:82MI0GT75Z

object_name: Alzheimer disease


subject: MESH:C526315


subject: CHEBI:94573

subject_name: Zibotentan

object_name: chronic kidney disease


subject: CHEBI:94573

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Sequelae of fracture of forearm and upper arm


subject: CHEBI:4466


subject: UNII:7N8K34P2XH


subject: UMLS:C1688504

subject_name: skin cleanser combination no.1

object_name: atopic eczema


subject: CHEBI:145421

subject_name: rigosertib sodium

object_name: recessive dystrophic epidermolysis bullosa


subject: UMLS:C4317276


subject: CHEBI:34945

object_name: Diabetes


subject: CHEBI:34945

object_name: diabetes mellitus


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: UNII:7662KG2R6K


subject: CHEMBL.COMPOUND:CHEMBL3544910

subject_name: MOTEXAFIN GADOLINIUM

object_name: Disseminated Malignant Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3544910

object_name: Embolism, Tumor


subject: CHEMBL.COMPOUND:CHEMBL3544910

object_name: Neoplasm Metastasis


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: myocardial infarction


subject: MESH:D000077203

object_name: Cardiomegaly


subject: CHEBI:87715

subject_name: Prasugrel

object_name: chronic asthma


subject: CHEBI:3561

subject_name: Cetirizine

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:91400

subject_name: Afatinib

object_name: Advanced Lung Non-Small Cell Squamous Carcinoma


subject: CHEBI:8382

subject_name: Prednisone


subject: UMLS:C4547850

object_name: type 2 diabetes mellitus


subject: UMLS:C0383956

subject_name: HBOC 201

object_name: anemia


subject: UMLS:C0383956

object_name: Anemia, CTCAE


subject: CHEBI:8499

subject_name: Propranolol

object_name: Klatskin Tumor


subject: CHEBI:4909

subject_name: Etodolac

object_name: liver carcinoma


subject: CHEBI:4909


subject: PUBCHEM.COMPOUND:9861622

subject_name: Ecopipam

object_name: Tourette syndrome


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: lung cancer


subject: CHEBI:38290

object_name: lung neoplasm


subject: CHEBI:38290

object_name: lung carcinoma


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4086557

object_name: cancer


subject: UMLS:C4086557

object_name: neoplasm


subject: UMLS:C5433441

object_name: Acute Ischemic Stroke


subject: UMLS:C5433441

object_name: Ischemic stroke


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: borderline personality disorder


subject: CHEBI:79033

subject_name: florbetaben F18

object_name: plasma cell myeloma


subject: UNII:CD7WXM716P

object_name: neuroendocrine neoplasm


subject: UNII:CD7WXM716P

object_name: APUdoma


subject: UNII:MRL3739G66

subject_name: Dotatate


subject: UNII:Y68179SY2L

object_name: Childhood Neuroblastoma


subject: UNII:Y68179SY2L

object_name: neuroblastoma


subject: UNII:Y68179SY2L


subject: CHEBI:63660

object_name: carcinoma of esophagus


subject: CHEBI:63660

object_name: esophageal cancer


subject: CHEBI:63660

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:63660

object_name: neoplasm of esophagus


subject: CHEBI:63660

object_name: Stomach cancer


subject: CHEBI:63660

object_name: gastric cancer


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: UMLS:C4330505

subject_name: JAK1 Inhibitor

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C4330505

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C4330505

object_name: Indolent T-cell lymphoproliferative disorder of gastrointestinal tract


subject: UMLS:C4330505

object_name: T-Cell Lymphoma


subject: UMLS:C4330505

object_name: Primary cutaneous acral CD8 positive T-cell lymphoma


subject: UMLS:C4330505

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C4330505

object_name: mycosis fungoides


subject: UMLS:C4330505

object_name: chronic lymphoproliferative disorder of NK-cells


subject: CHEBI:49662

subject_name: Indomethacin

object_name: chronic pancreatitis


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Anorectal Diseases


subject: CHEBI:6149

object_name: Drug action (disorder)


subject: MESH:C000726164

object_name: Disseminated Malignant Neoplasm


subject: MESH:C000726164

object_name: Embolism, Tumor


subject: MESH:C000726164

object_name: Neoplasm Metastasis


subject: MESH:C000726164

object_name: Advanced cancer


subject: MESH:C000726164

object_name: Neoplastic Processes


subject: MESH:C000726164

object_name: Pathologic Processes


subject: MESH:C000726164

object_name: neoplasm


subject: CHEBI:24433

subject_name: group

object_name: coronary artery disorder


subject: CHEBI:24433

object_name: coronary atherosclerosis


subject: CHEBI:90001

subject_name: cystathionine ketimine


subject: CHEBI:90001


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: UMLS:C2343930

subject_name: Lexiscan


subject: UMLS:C2343930


subject: CHEBI:33380

subject_name: thulium atom


subject: CHEBI:33380


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: CHEBI:4708

subject_name: Doxazosin

object_name: impotence


subject: CHEBI:4708

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:4708

object_name: Erectile dysfunction


subject: CHEBI:9398

subject_name: Tamsulosin


subject: CHEBI:9398


subject: CHEBI:9398


subject: UMLS:C5396052

subject_name: Inactivated whole Hepatitis A virus antigen only vaccine product

object_name: Vaccine-Preventable Diseases


subject: CHEMBL.COMPOUND:CHEMBL5314990

subject_name: LONIGUTAMAB

object_name: euthyroid Graves orbitopathy


subject: CHEMBL.COMPOUND:CHEMBL5314990

object_name: endocrine exophthalmos


subject: UMLS:C5670988

subject_name: Lonigutamab


subject: UMLS:C5670988


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:28072

object_name: non-small cell lung carcinoma


subject: CHEBI:70744

subject_name: Gly-Pro


subject: UniProtKB:P08668

subject_name: GP_HANTV Envelopment polyprotein (sprot)


subject: UniProtKB:P27312

subject_name: GP_PUUMS Envelopment polyprotein (sprot)


subject: UMLS:C1134696

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C5446373

subject_name: CDK2 Inhibitor PF-07104091

object_name: ovarian cancer


subject: UMLS:C5446373

object_name: ovarian neoplasm


subject: UMLS:C5446373

object_name: ovarian carcinoma


subject: UMLS:C5446373

object_name: small cell lung carcinoma


subject: UMLS:C5446373

object_name: Childhood Breast Carcinoma


subject: UMLS:C5446373

object_name: breast carcinoma


subject: UMLS:C5446373

object_name: breast cancer


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:27306

subject_name: vitamin B6

object_name: vitamin B12 deficiency


subject: CHEBI:27306

object_name: inborn disorder of cobalamin metabolism and transport


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:50838

subject_name: Drospirenone

object_name: acne


subject: CHEBI:50859

subject_name: Bexarotene

object_name: schizophrenia


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Stress


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)


subject: CHEBI:91834

subject_name: Articaine

object_name: Post-Operative Pain


subject: UMLS:C5814269

object_name: hereditary angioedema


subject: CHEBI:15738

subject_name: Staurosporine

object_name: systemic sclerosis


subject: CHEBI:15738

object_name: adult dermatomyositis


subject: CHEBI:15738

object_name: dermatomyositis


subject: MESH:D016324

subject_name: Sequence Tagged Sites


subject: MESH:D016324


subject: MESH:D016324


subject: CHEBI:132112


subject: CHEBI:75275

subject_name: Tetradecyl hydrogen sulfate (ester)


subject: CHEBI:75275


subject: CHEBI:75275


subject: CHEBI:231601

subject_name: trastuzumab

object_name: transitional cell carcinoma


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: PUBCHEM.COMPOUND:23594367

subject_name: Boceprevir

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:23594367

object_name: Chronic uremia


subject: UMLS:C0982327

subject_name: PEGINTERFERON


subject: UMLS:C0982327


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:16899

subject_name: Mannitol

object_name: renal carcinoma


subject: MESH:C000627770

subject_name: folfirinox

object_name: biliary tract cancer


subject: MESH:C000627770

object_name: liver carcinoma


subject: CHEBI:35366

subject_name: fatty acid

object_name: mild neurocognitive disorder


subject: CHEBI:35366

object_name: mild cognitive impairment


subject: CHEBI:8382

subject_name: Prednisone

object_name: cellulitis


subject: CHEBI:8382

object_name: cellulitis on exam (physical finding)


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Arterial Stiffness


subject: CHEBI:77562

subject_name: rac-crizotinib


subject: CHEBI:77562

object_name: renal cell carcinoma


subject: CHEBI:77562

object_name: glioblastoma


subject: CHEBI:77562

object_name: Childhood Glioblastoma


subject: CHEBI:77562

object_name: adult glioblastoma


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:66910


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: neoplasm


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:6413

subject_name: Letrozole

object_name: Ovulation disorder


subject: CHEBI:6413

object_name: paroxysmal familial ventricular fibrillation


subject: CHEBI:6413

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: UNII:F333OQQ9UV


subject: CHEMBL.COMPOUND:CHEMBL4297886

subject_name: ASUNERCEPT


subject: UMLS:C5139847

subject_name: Asunercept


subject: UNII:J8AY0Z4CBP

object_name: cancer


subject: UNII:J8AY0Z4CBP


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: PUBCHEM.COMPOUND:53378893

subject_name: Kinase inhibitor


subject: PUBCHEM.COMPOUND:53378893


subject: UMLS:C4079992

object_name: atopic conjunctivitis


subject: UMLS:C0282575

subject_name: Micronutrients

object_name: Pregnant


subject: UMLS:C0282575

object_name: preeclampsia


subject: CHEBI:145374

subject_name: Enasidenib

object_name: Hepatic impairment


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Ovarian hyperstimulation


subject: CHEBI:31527

object_name: female infertility due to zona pellucida defect


subject: CHEBI:31527


subject: CHEBI:31527


subject: CHEBI:31355

subject_name: Carboplatin

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:31355

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: chronic myelomonocytic leukemia


subject: CHEBI:33330

subject_name: scandium atom

object_name: acute myeloid leukemia


subject: CHEBI:33330


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000007182


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PR:000050188


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Arterial thrombosis


subject: CHEBI:73604

object_name: venous thromboembolism


subject: CHEBI:73604

object_name: thrombophilia due to thrombin defect


subject: UMLS:C4725065

subject_name: WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401

object_name: urothelial carcinoma


subject: UMLS:C4725065

object_name: transitional cell carcinoma


subject: UMLS:C3896834

subject_name: Dna plasmid encoding interleukin-12 ino-9012


subject: UMLS:C3896834


subject: CHEBI:24866

subject_name: salt

object_name: Reduced blood folate concentration


subject: CHEBI:24866

object_name: neural tube defect


subject: CHEBI:24866

object_name: neural tube defects, susceptibility to


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:24859

subject_name: iodine atom


subject: CHEBI:24859


subject: CHEBI:24859


subject: CHEBI:17606

subject_name: Iodine


subject: CHEBI:17606


subject: CHEBI:17606


subject: UMLS:C0885449

subject_name: Iodine, Homeopathic preparation


subject: UMLS:C0885449


subject: UMLS:C0885449


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: stroke disorder


subject: CHEBI:31355

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:31355

object_name: Non-small cell carcinoma of lung, TNM stage 4


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:22023730

subject_name: Ganaxolone

object_name: tuberous sclerosis 1


subject: UMLS:C0499022

subject_name: INJECTION, DIAZEPAM, UP TO 5 MG ADMINISTERED

object_name: epilepsy


subject: UMLS:C0499022

object_name: Seizure Related to COVID-19


subject: UMLS:C0499022

object_name: visual epilepsy


subject: UMLS:C0499022

object_name: generalized epilepsy


subject: UMLS:C0499022

object_name: complex partial epilepsy


subject: UMLS:C0499022

object_name: focal epilepsy


subject: UMLS:C4048461

subject_name: Diazepam Injection


subject: UMLS:C4048461


subject: UMLS:C4048461


subject: UMLS:C4048461


subject: UMLS:C4048461


subject: UMLS:C4048461


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: Cervical myelopathy


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: colorectal neoplasm


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: cholangiocarcinoma of the gallbladder


subject: PUBCHEM.COMPOUND:2767

object_name: Localized Gallbladder Carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Unresectable Gallbladder Carcinoma


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Norepinephrine adverse reaction


subject: CHEBI:18357

subject_name: Norepinephrine


subject: UMLS:C3274844

object_name: Muscle Atrophy


subject: UMLS:C1647218

subject_name: COPD pharmacologic substance

object_name: chronic obstructive pulmonary disease


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:82677

object_name: Myelodysplasia


subject: CHEBI:82677

object_name: Myeloid Metaplasia


subject: CHEBI:82677

object_name: leukemia


subject: CHEBI:82677

object_name: childhood leukemia


subject: CHEBI:82677

object_name: adult lymphoma


subject: CHEBI:82677

object_name: lymphoma


subject: CHEBI:82677

object_name: pediatric lymphoma


subject: CHEBI:82677

object_name: myelofibrosis


subject: UMLS:C0597641

subject_name: plasmid vaccine

object_name: HIV infection


subject: CHEBI:82978

subject_name: paliperidone

object_name: methamphetamine dependence


subject: CHEBI:188072


subject: CHEBI:83804

subject_name: Paliperidone


subject: UMLS:C4744685

object_name: EXCESS LMW-DNA


subject: UMLS:C4744685

object_name: st. Louis encephalitis


subject: UMLS:C4256365

subject_name: Xtampza ER

object_name: chronic pain (diagnosis)


subject: UMLS:C4256365

object_name: Chronic pain


subject: UMLS:C4256365

object_name: opioid use


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: migraine


subject: CHEBI:17045

object_name: migraine with or without aura, susceptibility to, 1


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: Hemorrhage


subject: CHEBI:71025

subject_name: ulipristal


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: viral disease


subject: CHEBI:465284

object_name: posterior uveitis


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: type 2 diabetes mellitus


subject: CHEBI:53760

object_name: Insulin resistance


subject: UMLS:C5785376

subject_name: Metabolic Anti-cancer Agent ASCA101

object_name: Childhood Solid Neoplasm


subject: UMLS:C5785376

object_name: Adult Solid Neoplasm


subject: UMLS:C5785376

object_name: Solid Neoplasm


subject: CHEBI:33364

subject_name: Platinum

object_name: digestive system neoplasm


subject: CHEBI:33364

object_name: Neoplasm of the gastrointestinal tract


subject: CHEMBL.COMPOUND:CHEMBL1235478

subject_name: PLATINUM


subject: CHEMBL.COMPOUND:CHEMBL1235478


subject: UMLS:C1171558

subject_name: Platinum metallicum, platinum, Homeopathic preparation


subject: UMLS:C1171558


subject: GTOPDB:12989

subject_name: toripalimab

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:12989

object_name: renal cell adenocarcinoma


subject: GTOPDB:12989

object_name: renal cell carcinoma


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: food allergy


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Hypersensitivity reaction caused by food


subject: DRUGBANK:DB16615

subject_name: Krill oil


subject: DRUGBANK:DB16615


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Unresectable Hepatocellular Carcinoma


subject: GTOPDB:9592

object_name: Oligometastatic malignant neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68647

subject_name: Regorafenib


subject: UNII:8GJK87S89F

subject_name: TREPROSTINIL PALMITIL

object_name: pulmonary hypertension, primary, 1


subject: UNII:8GJK87S89F

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:8GJK87S89F

object_name: pulmonary arterial hypertension


subject: DRUGBANK:DB18792

subject_name: Treprostinil palmitil


subject: DRUGBANK:DB18792


subject: DRUGBANK:DB18792


subject: UMLS:C4283865

subject_name: Choline c-11, diagnostic, per study dose up to 20 millicuries

object_name: carcinoma of esophagus


subject: UMLS:C4283865

object_name: esophageal cancer


subject: UMLS:C4283865

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4283865

object_name: neoplasm of esophagus


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:15354


subject: CHEBI:15354


subject: CHEBI:15354


subject: CHEBI:74947

subject_name: Thalidomide

object_name: HIV wasting syndrome


subject: UNII:45X7OU8C4J

subject_name: DOMVANALIMAB

object_name: melanoma


subject: UMLS:C5206853

subject_name: Domvanalimab


subject: GTOPDB:12349

subject_name: zimberelimab


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: CHEBI:4856

subject_name: Esmolol

object_name: Injection site irritation


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: IgA Nephropathy


subject: CHEBI:135949

object_name: proteinuria


subject: CHEBI:135949

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:135949

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:135949

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:135949

object_name: chronic kidney disease


subject: CHEBI:135949

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:23359

subject_name: colchicine

object_name: abdominal aortic aneurysm


subject: CHEBI:23359

object_name: aortic aneurysm, familial abdominal, 1


subject: CHEBI:23359

object_name: Disease Progression


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: pancreatitis


subject: CHEBI:17650

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:17650

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:17650

object_name: acute pancreatitis


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: pancreatic adenocarcinoma


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: infective endocarditis


subject: CHEBI:90001

object_name: bacterial endocarditis


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:37941

object_name: metabolic syndrome X


subject: CHEBI:6704

subject_name: Mebendazole

object_name: colorectal cancer


subject: CHEBI:6704

object_name: colorectal carcinoma


subject: CHEBI:6704

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Community-Acquired Pneumonia


subject: CHEBI:9150

object_name: Heart Disease Risk Factors


subject: CHEBI:75998

subject_name: Trametinib

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:75998

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:75045

subject_name: Dabrafenib


subject: CHEBI:75045


subject: CHEBI:75045


subject: CHEBI:233453

object_name: cytomegalovirus infection


subject: CHEBI:233453

object_name: viral disease


subject: CHEBI:35854

subject_name: Valaciclovir


subject: UMLS:C3274144

subject_name: Zelitrex


subject: UMLS:C3274144


subject: CHEBI:8382

subject_name: Prednisone

object_name: Friedreich ataxia


subject: CHEBI:8382

object_name: Friedreich ataxia 1


subject: CHEBI:8382

object_name: Cardiomegaly


subject: CHEBI:8382

object_name: Myocardial fibrosis


subject: CHEBI:36791

subject_name: Escitalopram

object_name: male infertility


subject: CHEBI:3723

subject_name: Citalopram


subject: UMLS:C0784217

subject_name: salt substitutes

object_name: kidney neoplasm


subject: UMLS:C0784217

object_name: chronic kidney disease


subject: UNII:HJT620308C

subject_name: SALT SUBSTITUTE


subject: UNII:HJT620308C


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: nicotine dependence


subject: UNII:PX9FTM69BF

subject_name: Vimseltinib

object_name: tenosynovial giant cell tumor


subject: UNII:PX9FTM69BF

object_name: tenosynovial giant cell tumor, diffuse type


subject: UNII:PX9FTM69BF

object_name: Advanced cancer


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Sweat gland pore closure


subject: CHEBI:41139

subject_name: BETAINE

object_name: increased; permeability


subject: CHEBI:41139

object_name: metabolic disturbance


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Metastatic malignant neoplasm to bone


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Overweight


subject: UniProtKB:Q54NS9

subject_name: AIFA_DICDI Apoptosis-inducing factor homolog A (sprot)

object_name: schizophrenia


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: carotid atherosclerosis


subject: CHEBI:66903

subject_name: Vismodegib

object_name: Locally Advanced Basal Cell Carcinoma


subject: CHEBI:66903

object_name: Metastatic basal cell carcinoma


subject: CHEBI:177705

subject_name: Birinapant

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:177705

object_name: Recurrent ovarian cancer


subject: CHEBI:177705

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:177705

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:177705

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:177705

object_name: high grade ovarian serous adenocarcinoma


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:266052

subject_name: Vitamin


subject: MESH:D014131

subject_name: Trace Elements


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: glioma


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: ulcer disease


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Emergence Delirium


subject: CHEBI:39548

object_name: post-operative delirium


subject: CHEBI:39548

object_name: delirium


subject: CHEBI:39548

object_name: Delirium, CTCAE


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: CHEBI:6801

subject_name: Metformin

object_name: Metformin associated lactic acidosis


subject: UNII:38K542K6ZV

subject_name: ISOPHANE INSULIN HUMAN SUSPENSION

object_name: acute myocardial infarction


subject: UNII:38K542K6ZV

object_name: Acute Myocardial Infarction by ECG Finding


subject: UNII:38K542K6ZV

object_name: type 2 diabetes mellitus


subject: CHEBI:232799

subject_name: insulin lispro


subject: CHEBI:232799


subject: UNII:2P6O7CFW5K

subject_name: Triheptanoin

object_name: adult polyglucosan body disease


subject: UNII:2P6O7CFW5K

object_name: glycogen storage disease due to glycogen branching enzyme deficiency


subject: CHEMBL.COMPOUND:CHEMBL4297251

subject_name: ORANGE JUICE

object_name: Fetal distress


subject: CHEBI:9123

subject_name: Sertraline

object_name: acute stress disorder


subject: DRUGBANK:DB16369

subject_name: Matrix-M


subject: CHEMBL.COMPOUND:CHEMBL4650407

subject_name: MATRIX-M1 ADJUVANT


subject: UMLS:C4722369

object_name: colorectal neoplasm


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: plasma cell myeloma


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: oligospermia


subject: CHEBI:6503

object_name: Oligospermia, CTCAE


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: UMLS:C0247947

subject_name: exendin (9-39)

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0247947

object_name: obesity


subject: UMLS:C0247947

object_name: Obesity, CTCAE


subject: UNII:N824AOU5XV

subject_name: Pegvisomant


subject: UNII:N824AOU5XV


subject: UNII:N824AOU5XV


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: arthritis


subject: CHEBI:168396

object_name: Arthritis, CTCAE


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: leukopenia


subject: CHEBI:73604

object_name: neutropenia


subject: UNII:D0VK52NV5M

subject_name: Asimadoline

object_name: atopic eczema


subject: UNII:D0VK52NV5M

object_name: Pruritus, CTCAE


subject: UNII:D0VK52NV5M

object_name: Pruritus


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage IV Hepatocellular Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage III Hepatocellular Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IVA Hepatocellular Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IVB Hepatocellular Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIC Hepatocellular Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Advanced Adult Hepatocellular Carcinoma


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:17925

object_name: coronary microvascular disorder


subject: CHEBI:17925

object_name: glucose metabolism disease


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:17234


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: liver failure


subject: UMLS:C4733274

subject_name: Muscadine Plus

object_name: prostate adenocarcinoma


subject: MESH:D010919

subject_name: Placebos


subject: UNII:Q6U6J48BWY

subject_name: Imiglucerase

object_name: Gaucher disease


subject: PR:000007867

subject_name: lysosomal acid glucosylceramidase


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN

object_name: VABP


subject: CHEBI:37943

subject_name: colistin


subject: UMLS:C4733468

subject_name: CriPec® docetaxel

object_name: Solid Neoplasm


subject: UMLS:C4733468

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4733468

object_name: Embolism, Tumor


subject: UMLS:C4733468

object_name: Neoplasm Metastasis


subject: UMLS:C4733468

object_name: cancer


subject: UMLS:C4733468

object_name: neoplasm


subject: CHEBI:2677

subject_name: Augmentin

object_name: Acute sinusitis


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: PUBCHEM.COMPOUND:3222

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:3222

object_name: heart disorder


subject: PUBCHEM.COMPOUND:3222

object_name: cardiomyopathy


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:6427

subject_name: Leuprolide

object_name: precocious puberty


subject: CHEBI:6520

subject_name: Lomustine

object_name: neoplastic syndrome


subject: CHEBI:6520


subject: CHEBI:6520

object_name: neoplastic disease or syndrome


subject: CHEBI:9637

subject_name: Torasemide


subject: DRUGBANK:DB18646

object_name: acquired polycythemia vera


subject: PUBCHEM.COMPOUND:437954

subject_name: Hematoporphyrin Derivative

object_name: lung cancer


subject: PUBCHEM.COMPOUND:437954

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:437954

object_name: lung carcinoma


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: plasma cell myeloma


subject: UNII:4EQZ6YO2HI

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UNII:TL60C27RLH

subject_name: Metreleptin

object_name: lipodystrophy


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: atrial fibrillation


subject: CHEBI:3215

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:3215

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:31964

subject_name: Pazufloxacin

object_name: bacterial conjunctivitis


subject: CHEBI:47458

subject_name: Saracatinib

object_name: pediatric osteosarcoma


subject: CHEBI:47458

object_name: Osteosarcoma


subject: UMLS:C0081934

subject_name: ccaat transcription factor efi(a)

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C0081934

object_name: pulmonary hypertension


subject: UMLS:C0081934

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C0081934

object_name: pulmonary arterial hypertension


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Premature ventricular contraction


subject: CHEBI:3441

object_name: Ventricular Premature Complex by ECG Finding


subject: UMLS:C0006055

subject_name: Botulinum Toxins

object_name: Chronic anal fissure


subject: CHEBI:60799

subject_name: Esketamine

object_name: Inflammatory Response


subject: CHEBI:60799

object_name: Immunosuppression


subject: CHEBI:60799

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:60799

object_name: Sepsis


subject: CHEBI:60799

object_name: Sepsis, CTCAE


subject: CHEBI:82339

subject_name: Merphalan

object_name: malignant soft tissue neoplasm


subject: CHEBI:82339

object_name: sarcoma


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: PR:000029153

subject_name: delta-hemolysin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PR:000029153

object_name: obesity


subject: PR:000029153

object_name: Obesity, CTCAE


subject: PR:000029153

object_name: colon carcinoma


subject: PR:000029153

object_name: colorectal cancer


subject: PR:000029153

object_name: colon cancer


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: neoplasm


subject: CHEBI:46081

subject_name: Fluconazole


subject: UNII:6897GXD6OE

object_name: Restless legs


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Pancreatic carcinoma stage II


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IV pancreatic cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:230905

subject_name: Ribociclib

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C1948073

object_name: pancreatic neoplasm


subject: UMLS:C1948073

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1948073

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:74413906

subject_name: Cobalamin

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:74413906

object_name: Increased reactive oxygen species production


subject: PUBCHEM.COMPOUND:74413906

object_name: Drug-Induced Movement Disorder, Unspecified


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: CHEBI:28911


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439

subject_name: Cyanocobalamin


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class


subject: UMLS:C3714638


subject: UMLS:C3714638


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:94265

subject_name: Cerubidin

object_name: childhood acute myeloid leukemia


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:91464


subject: CHEBI:63452

subject_name: Midostaurin


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: Alzheimer disease


subject: CHEBI:3636

subject_name: Chloroprocaine

object_name: cervical incompetence


subject: CHEBI:37537

subject_name: Phorbol 12-myristate 13-acetate diester

object_name: Openbite teeth | Teeth and gum | Dental


subject: CHEBI:15702


subject: CHEBI:53394

subject_name: phosphotungstic acid macromolecule


subject: CHEBI:61432

subject_name: phosphotungstic acid polymer


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: UNII:05HYK3CV9N

subject_name: Linperlisib

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: hemophilia A


subject: UNII:Q46947FE7K

object_name: hemophilia


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Fused vertebrae


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: recurrent gastric cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Esophageal Cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Gastric Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Gastric Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Gastric Mixed Adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: diffuse gastric adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: gastric intestinal type adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UMLS:C1258613

subject_name: oblimersen sodium


subject: UMLS:C1258613

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C1258613


subject: UMLS:C1258613

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C1258613


subject: UMLS:C1258613


subject: UMLS:C1258613


subject: UMLS:C1258613


subject: UMLS:C1258613


subject: UMLS:C1258613

object_name: Stage IV Esophageal Cancer AJCC v6


subject: UMLS:C1258613

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UMLS:C1258613

object_name: stage IV esophageal cancer


subject: UMLS:C1258613

object_name: esophageal adenocarcinoma


subject: UMLS:C1258613

object_name: esophageal squamous cell carcinoma


subject: UMLS:C1258613


subject: UMLS:C1258613


subject: UMLS:C1258613


subject: CHEBI:36796

subject_name: duloxetine

object_name: EXCESS LMW-DNA


subject: UMLS:C1134528

subject_name: NY-ESO-1 peptide vaccine

object_name: Ovarian cancer stage III


subject: UMLS:C1134528

object_name: Carcinoma of ovary, stage 3


subject: UMLS:C1134528

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1134528

object_name: Ovarian cancer stage IV


subject: UMLS:C1134528

object_name: malignant neoplasm of ovary stage IV


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: PUBCHEM.COMPOUND:174489

object_name: Hemorrhage


subject: PUBCHEM.COMPOUND:174489

object_name: Extracorporeal membrane oxygenation complication


subject: PUBCHEM.COMPOUND:174489

object_name: respiratory failure


subject: PUBCHEM.COMPOUND:174489

object_name: acute respiratory failure


subject: DRUGBANK:DB14296

subject_name: Panax quinquefolius whole

object_name: type 2 diabetes mellitus


subject: GTOPDB:12990

subject_name: sintilimab

object_name: thyroid tumor


subject: GTOPDB:12990

object_name: thyroid gland carcinoma


subject: GTOPDB:12990

object_name: thyroid cancer


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: malignant epithelial tumor of ovary


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent disease


subject: PUBCHEM.COMPOUND:43805

object_name: Global Relapse in Viscera


subject: PUBCHEM.COMPOUND:43805

object_name: Global Relapse in Lymph Nodes


subject: PUBCHEM.COMPOUND:43805

object_name: Relapse Following Intervention for Kawasaki Disease


subject: PUBCHEM.COMPOUND:43805

object_name: Global Relapse


subject: PUBCHEM.COMPOUND:43805

object_name: Global Relapse in Skin


subject: PUBCHEM.COMPOUND:43805

object_name: Global Relapse in Blood


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: hyperparathyroidism


subject: CHEBI:4466

object_name: Hyperparathyroidism, CTCAE


subject: CHEBI:4466

object_name: benign thyroid gland neoplasm


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Diabetic foot ulcer


subject: CHEBI:144903

object_name: familial pityriasis rubra pilaris


subject: CHEBI:144903

object_name: pityriasis rubra pilaris


subject: CHEBI:144903

object_name: Skin lesion


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: PR:000032963


subject: CHEBI:33349

subject_name: dubnium atom


subject: CHEBI:33349


subject: CHEBI:33349


subject: CHEBI:33349


subject: CHEBI:33357

subject_name: hassium atom


subject: CHEBI:33357


subject: CHEBI:33357


subject: CHEBI:33357


subject: CHEBI:133630

subject_name: His-Ala


subject: CHEBI:133630


subject: CHEBI:133630


subject: CHEBI:133630


subject: UniProtKB:P03456

subject_name: HEMA_I68A3 Hemagglutinin (sprot)


subject: UniProtKB:P03456


subject: UniProtKB:P03456


subject: UniProtKB:P03456


subject: UniProtKB:P03446

subject_name: HEMA_I76A2 Hemagglutinin (sprot)


subject: UniProtKB:P03446


subject: UniProtKB:P03446


subject: UniProtKB:P03446


subject: UniProtKB:A3DRP0

subject_name: HEMA_I96A2 Hemagglutinin (sprot)


subject: UniProtKB:A3DRP0


subject: UniProtKB:A3DRP0


subject: UniProtKB:A3DRP0


subject: UniProtKB:A4K143

subject_name: HEMA_I54A2 Hemagglutinin (sprot)


subject: UniProtKB:A4K143


subject: UniProtKB:A4K143


subject: UniProtKB:A4K143


subject: UniProtKB:B4URD6

subject_name: HEMA_I06A0 Hemagglutinin (sprot)


subject: UniProtKB:B4URD6


subject: UniProtKB:B4URD6


subject: UniProtKB:B4URD6


subject: UniProtKB:Q0A448

subject_name: hemagglutinin (Influenza A virus (strain A/Duck/Germany/1949 H10N7))


subject: UniProtKB:Q0A448


subject: UniProtKB:Q0A448


subject: UniProtKB:Q0A448


subject: UMLS:C4285347

subject_name: Ha Antibody


subject: UMLS:C4285347


subject: UMLS:C4285347


subject: UMLS:C4285347


subject: UniProtKB:Q9WCD8

subject_name: HEMA_I61A1 Hemagglutinin (sprot)


subject: UniProtKB:Q9WCD8


subject: UniProtKB:Q9WCD8


subject: UniProtKB:Q9WCD8


subject: UniProtKB:P03453

subject_name: HEMA_I77AB Hemagglutinin (sprot)


subject: UniProtKB:P03453


subject: UniProtKB:P03453


subject: UniProtKB:P03453


subject: UniProtKB:A4U7A6

subject_name: HEMA_I51A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U7A6


subject: UniProtKB:A4U7A6


subject: UniProtKB:A4U7A6


subject: UniProtKB:P13103

subject_name: HEMA_I77AF Hemagglutinin (sprot)


subject: UniProtKB:P13103


subject: UniProtKB:P13103


subject: UniProtKB:P13103


subject: UniProtKB:P26136

subject_name: HEMA_I82A1 Hemagglutinin (sprot)


subject: UniProtKB:P26136


subject: UniProtKB:P26136


subject: UniProtKB:P26136


subject: UniProtKB:P07976

subject_name: HEMA_I83A5 Hemagglutinin (sprot)


subject: UniProtKB:P07976


subject: UniProtKB:P07976


subject: UniProtKB:P07976


subject: UniProtKB:A4GBX7

subject_name: HEMA_I77AA Hemagglutinin (sprot)


subject: UniProtKB:A4GBX7


subject: UniProtKB:A4GBX7


subject: UniProtKB:A4GBX7


subject: UniProtKB:P19698

subject_name: HEMA_I79A7 Hemagglutinin (sprot)


subject: UniProtKB:P19698


subject: UniProtKB:P19698


subject: UniProtKB:P19698


subject: UniProtKB:Q6LEJ4

subject_name: HEMA_I80A2 Hemagglutinin (sprot)


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:P03457

subject_name: HEMA_I66A1 Hemagglutinin (sprot)


subject: UniProtKB:P03457


subject: UniProtKB:P03457


subject: UniProtKB:P03457


subject: UniProtKB:A4GCL9

subject_name: HEMA_I35A3 Hemagglutinin (sprot)


subject: UniProtKB:A4GCL9


subject: UniProtKB:A4GCL9


subject: UniProtKB:A4GCL9


subject: UniProtKB:Q9WFX3

subject_name: HEMA_I18A0 Hemagglutinin (sprot)


subject: UniProtKB:Q9WFX3


subject: UniProtKB:Q9WFX3


subject: UniProtKB:Q9WFX3


subject: UniProtKB:A4U6V2

subject_name: HEMA_I45A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U6V2


subject: UniProtKB:A4U6V2


subject: UniProtKB:A4U6V2


subject: UniProtKB:Q07FI5

subject_name: HEMA_I96A3 Hemagglutinin (sprot)


subject: UniProtKB:Q07FI5


subject: UniProtKB:Q07FI5


subject: UniProtKB:Q07FI5


subject: UniProtKB:P03454

subject_name: HEMA_I33A0 Hemagglutinin (sprot)


subject: UniProtKB:P03454


subject: UniProtKB:P03454


subject: UniProtKB:P03454


subject: UniProtKB:A4GCK8

subject_name: HEMA_I43A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCK8


subject: UniProtKB:A4GCK8


subject: UniProtKB:A4GCK8


subject: UniProtKB:P03448

subject_name: HEMA_I72A5 Hemagglutinin (sprot)


subject: UniProtKB:P03448


subject: UniProtKB:P03448


subject: UniProtKB:P03448


subject: UniProtKB:A4GCI6

subject_name: HEMA_I36A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCJ7

subject_name: HEMA_I80AA Hemagglutinin (sprot)


subject: UniProtKB:A4GCJ7


subject: UniProtKB:A4GCJ7


subject: UniProtKB:A4GCJ7


subject: UniProtKB:P04661

subject_name: HEMA_I56A2 Hemagglutinin (sprot)


subject: UniProtKB:P04661


subject: UniProtKB:P04661


subject: UniProtKB:P04661


subject: UniProtKB:Q0HD60

subject_name: HEMA_I40A0 Hemagglutinin (sprot)


subject: UniProtKB:Q0HD60


subject: UniProtKB:Q0HD60


subject: UniProtKB:Q0HD60


subject: UniProtKB:P26139

subject_name: HEMA_I77A4 Hemagglutinin (sprot)


subject: UniProtKB:P26139


subject: UniProtKB:P26139


subject: UniProtKB:P26139


subject: UniProtKB:A4GCH5

subject_name: HEMA_I83A1 Hemagglutinin (sprot)


subject: UniProtKB:A4GCH5


subject: UniProtKB:A4GCH5


subject: UniProtKB:A4GCH5


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:231679

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:231679

object_name: Plasma cell myeloma recurrent


subject: CHEBI:231679

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:231679

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:231614

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:231614


subject: CHEBI:231614

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614

object_name: myeloproliferative neoplasm


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:45924

subject_name: Trimethoprim


subject: UMLS:C0041044


subject: CHEBI:135942

subject_name: Laropiprant

object_name: hyperlipidemia


subject: CHEBI:135942

object_name: hyperlipoproteinemia


subject: CHEBI:135942

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:135942

object_name: Serum lipids high (finding)


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: PUBCHEM.COMPOUND:10216733


subject: PUBCHEM.COMPOUND:10216733


subject: PUBCHEM.COMPOUND:10216733


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: heart disorder


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: UMLS:C3827171

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: binge eating


subject: CHEBI:8356

subject_name: Pramipexole


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Sprain of carpometacarpal joint


subject: UNII:UC95NQ339C

object_name: botulism


subject: UNII:UC95NQ339C

object_name: Thumb sprain


subject: UMLS:C0006055

subject_name: Botulinum Toxins